|
⚲
|
| Keyboard |
| RTW Investments LP
✚
|
|
|---|---|
| CRD # | 153232 |
| SEC # | 801-78183 |
| CIK # | 0001493215 |
| AUM | 14.14 B (2026-03-30) |
| Employees | 70 (50% Investors, 0% Brokers) |
| Phone | 646-597-6980 |
| Address | 40 10th Avenue New York, NY 10014 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] [Instagram] |
| Total AUM ($B) |
|---|
| In the News | |
|---|---|
| Thu, 23 Jul 2026 | RTW Investments swaps Allurion (ALUR) stock into pre-funded warrants — Stock Titan |
| Fri, 15 May 2026 | RTW Investments, Roderick Wong report 3.69M shares in Apellis (APLS) — Stock Titan |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Synta Pharmaceuticals Corp | 1.0 | ||
| Insmed Inc | 0.8 | ||
| Protagonist Therapeutics Inc | 0.5 | ||
| PTC Therapeutics Inc | 0.5 | ||
| Argenx SE | 0.5 | ||
| CG Oncology Inc | 0.5 | ||
| Celcuity Inc | 0.3 | ||
| BCTG Acquisition Corp | 0.3 | ||
| Erasca Inc | 0.3 | ||
| Natera Inc | 0.2 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | 4010 Royalty Investments ICAV | [2024-03-28] | 111.8 M | 284.4 M |
| Offered $111,770,000 · Filed 2025-04-29 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Commission $56,000 · Revenue Decline to Disclose | ||||
| HF | RTW Special Purpose Fund II LLC | [2019-11-04] | 16.4 M | 73.8 M |
| Filed 2019-11-18 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | RTW Special Purpose Fund I LLC | 2017-03-29 | 65.8 M | |
| HF | RTW Innovation Master Fund Ltd | [2016-03-30] | 918.4 M | 5,465.0 M |
| Filed 2025-07-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $10,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | RTW Innovation Offshore Fund Ltd | 2016-03-30 | ||
| HF | RTW Innovation Onshore Fund LP | 2016-03-30 | 11.0 M | |
| HF | RTW Master Fund Ltd | [2012-10-31] | 1,985.8 M | 7,355.5 M |
| Filed 2025-07-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $10,000,000 · Remaining Indefinite · Duration More than one year · Commission $8,900,000 · Net Assets Decline to Disclose | ||||
| HF | RTW Offshore Fund One Ltd | [2012-10-31] | 1.5 M | 183.9 M |
| Offered $1,453,279 · Filed 2022-05-02 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $10,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| HF | RTW Onshore Fund One LP | [2012-10-31] | 1,584.4 M | 290.0 M |
| Filed 2025-07-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $10,000,000 · Remaining Indefinite · Duration More than one year · Commission $13,700,000 · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 10 | 14.1 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 10 | 14.1 |
| By Discretionary | ||
| Discretionary | 10 | 14.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 10 | 14.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 6.8 | |
| United States Persons | 7.4 | |
| Total | 10 | 14.1 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Peter O'Leary | Director | 10 | 3 | |
| Jeffrey Brotman | Director | 6 | 3 | |
| Roderick Wong | Executive Officer | 14 | 2 | |
| Ef Capital Management | Executive Officer | 11 | 2 | |
| Rtw Fund Group GP LLC | Executive Officer, Promoter | 6 | 2 | |
| Rtw Investments LP | Promoter | 3 | 2 | |
| Agemian Patrick | Director | 2 | 2 | |
| Nathan Pelsma | Director | 2 | 2 | |
| 4010 Royalty Fund GP LLC | Promoter | 2 | 2 | |
| Dermot Hanley | Director | 2 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001493215] | |
| 3 | [0001493215] | |
| 4 | [0001493215] | |
| SC 13D | [0001493215] | |
| SC 13G | [0001493215] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 54930058PPKTSERDV366 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-12 | Grant | 991,544 | $1.67 | 1,655,878 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-12 | Grant | 96,896 | $1.67 | 161,816 |
|
Allurion Technologies Inc ALUR
Warrant (Right to Buy) · derivative
|
2025-11-12 | Grant | 767,848 | ||
|
Allurion Technologies Inc ALUR
Warrant (Right to Buy) · derivative
|
2025-11-12 | Grant | 991,544 | ||
|
Allurion Technologies Inc ALUR
Warrant (Right to Buy) · derivative
|
2025-11-12 | Grant | 96,896 | ||
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-12 | Grant | 767,848 | $1.67 | 1,282,306 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-05 | Conversion | 822,722 | $3.35 | 2,756,119 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-05 | Conversion | 37,863 | $3.35 | 126,841 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-11-05 | Conversion | 631,954 | $3.35 | 2,117,046 |
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Grant | $126,839.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Conversion | $2,117,044.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Grant | $2,117,044.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Conversion | $2,756,117.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Grant | $2,756,117.00 | ||
|
Allurion Technologies Inc ALUR
Convertible Note · derivative
|
2025-11-05 | Conversion | $126,839.00 | ||
|
Health Sciences Acquisitions Corp 2 OBIO
Pre-Funded Warrants (Right to Buy) · derivative
|
2025-08-04 | Buy | 3,636,363 | $2.75 | 9,999,998 |
|
Health Sciences Acquisitions Corp 2 OBIO
Common Stock
|
2025-04-30 | Buy | 49,900 | $2.99 | 149,201 |
|
Health Sciences Acquisitions Corp 2 OBIO
Common Stock
|
2025-04-29 | Buy | 50,000 | $2.53 | 126,500 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-04-16 | Conversion | 822,722 | $3.35 | 2,756,119 |
|
Allurion Technologies Inc ALUR
Common Stock, $0.0001 par value per share
|
2025-04-16 | Conversion | 37,863 | $3.35 | 126,841 |
| showing 20 of 151 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Blackstone Ireland Limited
✚
|
15.19 B | |
|
Abry Partners II LLC
✚
|
MA | 14.90 B |
|
Napier Park Global Capital US LP
✚
|
NY | 14.57 B |
|
BSP NY LLC
✚
|
NY | 14.24 B |
|
SRS Investment Management LLC
✚
|
NY | 13.92 B |
|
Dynasty Wealth Management LLC
✚
|
FL | 13.88 B |
|
LibreMax Capital LLC
✚
|
NY | 13.87 B |
|
Avoro Capital Advisors LLC
✚
|
NY | 13.55 B |
|
Eagle Point Credit Management LLC
✚
|
CT | 13.24 B |
|
Post Advisory Group LLC
✚
|
CA | 13.03 B |